Delegate Login
DO NAFLD PATIENTS ENGAGE WITH ADDITIONAL WEIGHT MANAGEMENT SUPPORT BETWEEN APPOINTMENTS?
Helen Mortimer, Sara Mancell and Emer Fitzpatrick
FIBRATES: AN ADJUVANT THERAPY FOR CHOLESTASIS IN PAEDIATRIC AGE GROUP
Tawhida Y. Abdelghaffar, Behairy A Bahairy, Hatem A Konsowa, Alif A Allam, Mary A Naguib and Huda Atta
LONG-TERM EFFICACY AND SAFETY OF ODEVIXIBAT, AN ILEAL BILE ACID TRANSPORTER INHIBITOR IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS: INTERIM RESULTS FROM PEDFIC 2, AN OPEN-LABEL PHASE 3 TRIAL
Richard J. Thompson, Reha Artan, Lorenzo D’Antiga, Roderick H.J. Houwen, Binita M. Kamath, Lise Kjems, Florence Lacaille, Jan P. Mattsson, Hasan Özen, Bertrand Roquelaure, Eyal Shteyer, Mary Elizabeth Tessier, Terese Wallefors, Natalie Warholic and Patrick Horn
OUTCOMES IN CHILDREN WITH PRIMARY SCLEROSING CHOLANGITIS OR AUTOIMMUNE HEPATITIS-OVERLAP AND ASSOCIATED INFLAMMATORY BOWEL DISEASE
Kavitha Jayaprakash, Ellen Paling, Olivia Bradshaw and Marumbo Mtegha
OUTCOMES OF PEDIATRIC LIVER TRANSPLANTATION, COMPARISON BETWEEN ACUTE AND CHRONIC LIVER FAILURE SETTINGS
Amr Alnagar, Khaled Daradka, Eirini Kyrana, Marumbo Methga, Karthikeyan Palaniswamy, Suzanne Davison, Patricia Mcclean, Sanjay Rajwal, Vivek Upasani, Vijayanand Dhakshinamoorthy, Raj Prasad and Magdy Attia
PREDICTORS OF PATIENT AND GRAFT SURVIVAL FOLLOWING PEDIATRIC LIVER TRANSPLANTATION: LONG-TERM ANALYSIS OF MORE THAN 300 CASES FROM SINGLE CENTRE
Amr Alnagar, Khaled Daradka, Eirini Kyrana, Marumbo Methga, Karthikeyan Palaniswamy, Suzanne Davison, Patricia Mcclean, Sanjay Rajwal, Vivek Upasani, Vijayanand Dhakshinamoorthy, Raj Prasad and Magdy Attia
REVIEW THE DIAGNOSIS OF IBD IN CHILDREN WITH AILD (AUTO IMMUNE LIVER DISEASE) -8 YEARS’ EXPERIENCE IN A TERTIARY CENTRE
Maria Misiou, Ben Hope, Huey Miin Lee, Marianne Samyn and Babu Vadamalayan
USE OF NILE RED TO ASSESS QUALITY OF STEATOTIC DONOR HUMAN HEPATOCYTES
Jasmine Singh, Maesha Deheragoda, Anil Dhawan and Ragai Mitry
DO NAFLD PATIENTS ENGAGE WITH ADDITIONAL WEIGHT MANAGEMENT SUPPORT BETWEEN APPOINTMENTS?
Helen Mortimer, Sara Mancell and Emer Fitzpatrick
FIBRATES: AN ADJUVANT THERAPY FOR CHOLESTASIS IN PAEDIATRIC AGE GROUP
Tawhida Y. Abdelghaffar, Behairy A Bahairy, Hatem A Konsowa, Alif A Allam, Mary A Naguib and Huda Atta
LONG-TERM EFFICACY AND SAFETY OF ODEVIXIBAT, AN ILEAL BILE ACID TRANSPORTER INHIBITOR IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS: INTERIM RESULTS FROM PEDFIC 2, AN OPEN-LABEL PHASE 3 TRIAL
Richard J. Thompson, Reha Artan, Lorenzo D’Antiga, Roderick H.J. Houwen, Binita M. Kamath, Lise Kjems, Florence Lacaille, Jan P. Mattsson, Hasan Özen, Bertrand Roquelaure, Eyal Shteyer, Mary Elizabeth Tessier, Terese Wallefors, Natalie Warholic and Patrick Horn
OUTCOMES IN CHILDREN WITH PRIMARY SCLEROSING CHOLANGITIS OR AUTOIMMUNE HEPATITIS-OVERLAP AND ASSOCIATED INFLAMMATORY BOWEL DISEASE
Kavitha Jayaprakash, Ellen Paling, Olivia Bradshaw and Marumbo Mtegha
OUTCOMES OF PEDIATRIC LIVER TRANSPLANTATION, COMPARISON BETWEEN ACUTE AND CHRONIC LIVER FAILURE SETTINGS
Amr Alnagar, Khaled Daradka, Eirini Kyrana, Marumbo Methga, Karthikeyan Palaniswamy, Suzanne Davison, Patricia Mcclean, Sanjay Rajwal, Vivek Upasani, Vijayanand Dhakshinamoorthy, Raj Prasad and Magdy Attia
PREDICTORS OF PATIENT AND GRAFT SURVIVAL FOLLOWING PEDIATRIC LIVER TRANSPLANTATION: LONG-TERM ANALYSIS OF MORE THAN 300 CASES FROM SINGLE CENTRE
Amr Alnagar, Khaled Daradka, Eirini Kyrana, Marumbo Methga, Karthikeyan Palaniswamy, Suzanne Davison, Patricia Mcclean, Sanjay Rajwal, Vivek Upasani, Vijayanand Dhakshinamoorthy, Raj Prasad and Magdy Attia
REVIEW THE DIAGNOSIS OF IBD IN CHILDREN WITH AILD (AUTO IMMUNE LIVER DISEASE) -8 YEARS’ EXPERIENCE IN A TERTIARY CENTRE
Maria Misiou, Ben Hope, Huey Miin Lee, Marianne Samyn and Babu Vadamalayan
USE OF NILE RED TO ASSESS QUALITY OF STEATOTIC DONOR HUMAN HEPATOCYTES
Jasmine Singh, Maesha Deheragoda, Anil Dhawan and Ragai Mitry